2023年度
原著・症例報告・総説 (英文のみ)
- Ikumi N, Fujita H. Long-term control of spondylitis by short-term ixekizumab treatment in a patient with palmoplantar pustulosis. J Dermatol. 2024 Feb 27. doi: 10.1111/1346-8138.17155. Epub ahead of print. PMID: 38414168.
- Fujita H, Iwasaki R, Tsuboi S, Murashiuma Y, Akiyama M. Regional differences in the prevalence of generalized pustular psoriasis in Japan. J Dermatol. 2024 Mar;51(3):380-390. doi: 10.1111/1346-8138.17089. Epub 2024 Jan 31. PMID: 38292005.
- Terui T, Okubo Y, Kobayashi S, Sano S, Morita A, Imafuku S, Tada Y, Abe M, Yaguchi M, Uehara N, Handa T, Tanaka M, Zhang W, Paris M, Murakami M. Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. Am J Clin Dermatol. 2024 Jan;25(1):165-167. doi: 10.1007/s40257-023-00825-0. Erratum for: Am J Clin Dermatol. 2023 Sep;24(5):837-847. PMID: 38060175; PMCID: PMC10796414.
- Miyamoto T, Izawa K, Masui S, Yamazaki A, Yamasaki Y, Matsubayashi T, Shiraki M, Ohnishi H, Yasumura J, Tomohiro K, Miyamae T, Matsubara T, Arakawa N, Ishige T, Takizawa T, Shimbo A, Shimizu M, Kimura N, Maeda Y, Maruyama Y, Shigemura T, Furuta J, Sato S, Tanaka H, Izumikawa M, Yamamura M, Hasegawa T, Kaneko H, Nakagishi Y, Nakano N, Iida Y, Nakamura T, Wakiguchi H, Hoshina T, Kawai T, Murakami K, Akizuki S, Morinobu A, Ohmura K, Eguchi K, Sonoda M, Ishimura M, Furuno K, Kashiwado M, Mori M, Kawahata K, Hayama K, Shimoyama K, Sasaki N, Ito T, Umebayashi H, Omori T, Nakamichi S, Dohmoto T, Hasegawa Y, Kawashima H, Watanabe S, Taguchi Y, Nakaseko H, Iwata N, Kohno H, Ando T, Ito Y, Kataoka Y, Saeki T, Kaneko U, Murase A, Hattori S, Nozawa T, Nishimura K, Nakano R, Watanabe M, Yashiro M, Nakamura T, Komai T, Kato K, Honda Y, Hiejima E, Yonezawa A, Bessho K, Okada S, Ohara O, Takita J, Yasumi T, Nishikomori R; Japan CAPS working group. Clinical characteristics of cryopyrin-associated periodic syndrome and long-term real-world efficacy and tolerability of canakinumab in Japan: results of a nationwide survey. Arthritis Rheumatol. 2024 Jan 25. doi: 10.1002/art.42808. Epub ahead of print. PMID: 38268504.
- Jain V, Giménez-Arnau A, Hayama K, Reich A, Carr W, Tillinghast J, Dahale S, Lheritier K, Walsh P, Zharkov A, Hugot S, Haemmerle S. Remibrutinib demonstrates favorable safety profile and sustained efficacy in chronic spontaneous urticaria over 52 weeks. J Allergy Clin Immunol. 2024 Feb;153(2):479-486.e4. doi: 10.1016/j.jaci.2023.10.007. Epub 2023 Oct 20. PMID: 37866460.
- Burden AD, Bissonnette R, Navarini AA, Murakami M, Morita A, Haeufel T, Ye B, Baehner F, Terui T. Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study. Dermatol Ther (Heidelb). 2023 Oct;13(10):2279-2297. doi: 10.1007/s13555-023-01002-1. Epub 2023 Sep 20. PMID: 37731086; PMCID: PMC10539230.
- Hayama K, Iwasaki R, Tian Y, Fujita H. Factors associated with generalized pustular psoriasis progression among patients with psoriasis vulgaris in Japan: Results from a claims database study. J Dermatol. 2023 Dec;50(12):1531-1538. doi: 10.1111/1346-8138.16949. Epub 2023 Sep 18. PMID: 37721393.
- Ikumi N, Fujita H, Wada TT. Generalized pustular psoriasis occurred immediately after the withdrawal of upadacitinib in a patient with plaque psoriasis with inflammatory arthritis. J Dermatol. 2023 Dec;50(12):e398-e399. doi: 10.1111/1346-8138.16901. Epub 2023 Jul 14. PMID: 37452475.
- Akiyama M, Takeichi T, Ikeda S, Ishiko A, Kurosawa M, Murota H, Shimomura Y, Suzuki T, Tamai K, Tanaka A, Terui T, Amagai M. Recent Advances in Clinical Research on Rare Intractable Hereditary Skin Diseases in Japan. Keio J Med. 2023 Jun 29. doi: 10.2302/kjm.2023-0008-IR. Epub ahead of print. PMID: 37380461.
- Hayashi N, Hayama K, Takahashi K, Kurokawa I, Okazaki M, Kashiwagi T, Iwashita E, Terui T. Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: A 52-week analysis of a postmarketing surveillance study in Japan. J Dermatol. 2023 Aug;50(8):1034-1044. doi: 10.1111/1346-8138.16835. Epub 2023 Jun 2. PMID: 37264993.
- Terui T, Okubo Y, Kobayashi S, Sano S, Morita A, Imafuku S, Tada Y, Abe M, Yaguchi M, Uehara N, Handa T, Tanaka M, Zhang W, Paris M, Murakami M. Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. Am J Clin Dermatol. 2023 Sep;24(5):837-847. doi: 10.1007/s40257-023-00788-2. Epub 2023 May 26. Erratum in: Am J Clin Dermatol. 2024 Jan;25(1):165-167. PMID: 37233897; PMCID: PMC10213585.
- Kitamura N, Kobayashi H, Nagasawa Y, Sugiyama K, Tsuzuki H, Tanikawa Y, Ikumi N, Okada Y, Takahashi Y, Asai S, Tamura N, Ogasawara M, Kawamoto T, Kuwatsuru R, Tamaki H, Kidoguchi G, Tateishi M, Kimura M, Mochida Y, Harigane K, Shimazaki T, Koike T, Tanimura K, Kataoka H, Amano K, Yasuoka H, Takei M. Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy. Int J Rheum Dis. 2023 Jun;26(6):1058-1066. doi: 10.1111/1756-185X.14695. Epub 2023 Apr 14. PMID: 37058849.
- Ikumi N, Fujita H. Generalized pustular psoriasis occurring in a patient with multiple sclerosis during treatment with fingolimod. J Dermatol. 2023 Sep;50(9):e295-e296. doi: 10.1111/1346-8138.16802. Epub 2023 Apr 5. PMID: 37017450.
2022年度
原著・症例報告・総説 (英文のみ)
- Hayashi N, Hayama K, Takahashi K, Kurokawa I, Okazaki M, Kashiwagi T, Iwashita E, Terui T: Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan. Journal of Dermatology 2022 Apr; 49(4): 411-421.
- Griffiths CEM, Gooderham M, Colombel JF, Terui T, Accioly AP, Gallo G, Zhu D, Blauvelt A: Safety of Ixekizumab in Adult Patients with Moderate-to-Severe Psoriasis: Data from 17 Clinical Trials with Over 18,000 Patient-Years of Exposure. Dermatology and Therapy (Heidelb) 2022 Jun; 12(6): 1431-1446.
- Hayama K, Fujita H: Improvement of dupilumab-associated conjunctivitis after switching to upadacitinib in a patient with atopic dermatitis. Dermatologic Therapy 2022 Jul; 35(7): e15575.
- Hayama K, Fujita H, Terui T: Current trend in the treatment of generalized pustular psoriasis in Japan: Results from a questionnaire-based epidemiological study. Journal of Dermatology 2022 Dec; 49(12): e439-e440.
- Maurer M, Berger W, Giménez-Arnau A, Hayama K, Jain V, Reich A, Haemmerle S, Lheritier K, Walsh P, Xia S, Storim J: Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria. Journal of Allergy and Clinical Immunology. 2022 Dec; 150(6): 1498-1506.
- Hayama K, Izaki S, Hayashi K, Kurosawa Y, Yamada S, Shimizu T, Gon Y, Fujita H: A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration. Postepy Dermatologii i Alergologii. 2022 Dec; 39(6): 1171-1173.
- Ikumi N, Fujita H: Clinically and radiologically successful treatment of spondylitis by guselkumab in a patient with pustulotic arthro-osteitis. Journal of Cutaneous Immunology and Allergy. 2023 Jan. [Online ahead of print]
- Choon SE, Elewski BE, Fujita H, Geng S, van de Kerkhof P, Mburu S, Puig L, Romiti R, Venturini M: Diversity in the clinical presentation of generalized pustular psoriasis (GPP): A series of case vignettes from around the world. Experimental Dermatology 2023 Aug;32(8):1284-1295.
- Shimizu K, Fujita H, Fujisawa D, Hayama K, Aoki S, Kubo A, Terui T: Case of type 1 segmental Darier's disease with a novel mosaic mutation in the ATP2A2 gene. Journal of Dermatology 2023 Aug;50(8):e240-e242.
2021年度
原著・症例報告・総説 (英文のみ)
- Nishimura-Tagui M, Hayama K, Fujita H, Miyamoto Y, Ishii N, Terui T: Disseminated Mycobacterium massiliense skin infection in an immunocompromised patient requiring long-term treatment. Journal of Dermatology 2021 Apr; 48(4): e201-e202.
- Toyoshima S, Sakamoto-Sasaki T, Kurosawa Y, Hayama K, Matsuda A, Watanabe Y, Terui T, Gon Y, Matsumoto K, Okayama Y: miR103a-3p in extracellular vesicles from FcεRI-aggregated human mast cells enhances IL-5 production by group 2 innate lymphoid cells. Journal of Allergy and Clinical Immunology 2021 May; 147(5): 1878-1891.
- Flora Farkas, Natsumi Ikumi, Musaab Elmamoun, Agnes Szentpetery, Oliver FitzGerald: Comparison of Composite Measure Remission Targets in Psoriatic Arthritis. Journal of Rheumatology 2021 Aug; 48(8): 1272-1278.
- Nishimori N, Toyoshima S, Sasaki-Sakamoto T, Hayama K, Terui T, Okayama Y: Serum level of hemokinin-1 is significantly lower in patients with chronic spontaneous urticaria than in healthy subjects. Allergology International 2021 Oct; 70(4): 480-488.
- Ikumi N, Hayama K, Terui T, Kitamura N, Takei M, Fujita H: Retrospective study of the differences in the management for pustulotic arthro-osteitis in patients with palmoplantar pustulosis between dermatologists and rheumatologists. Journal of Dermatology 2021 Nov; 48(11): e551- e553.
- Okubo Y, Morishima H, Zheng R, Terui T: Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study. Journal of Dermatology 2021 Dec; 48(12): 1838-1853.
- Ikumi N, Terui T, Fujita H: Peripheral arthritis presenting pencil-in-cup deformity in a patient with palmoplantar pustulosis. Journal of Dermatology 2021 Dec; 48(12): e612- e613.
- Nagaoka-Takatori A, Ishii M, Hayama K, Obinata D, Yamaguchi K, Takahashi S, Fujita H: A Case of IgA Vasculitis During Nivolumab Therapy for Renal Cell Carcinoma. Clinical, cosmetic and investigational dermatology 2021 Dec; 24(14): 1885-1888.
- Hayama K, Fujita H, Hashimoto T, Terui T: Overall Impairment of Quality of Life in Japanese Patients with Hidradenitis Suppurativa: Comparison with National Standard. Acta Dermato- Venereologia 2022 Jan; 102: adv00632.
- Nishimori N, Niwa Y, Kazama A, Yamamoto M, Fujita H: Extensive expression of SARS-CoV-2 spike protein from the eccrine secretory gland to acrosyringium in the maculopapular eruption of a COVID-19 patient. Journal of Dermatology 2022 Jan; 49(1): e11-e12.
- Asakura M, Yoshida K, Ishii M, Fujita H: Case of oral glycogenic acanthosis clinically resembling lichen planus. Journal of Dermatology 2022 Mar; 49(3): 119-120.
- Saeki H, Tsunemi Y, Arai S, Ichiyama S, Katoh N, Kikuchi K, Kubo A, Terui T, Nakahara T, Futamura M, Murota H, Igarashi A: English version of guidelines for the management of asteatosis 2021 in Japan. Journal of Dermatology 2022 Mar; 49(3): e77-e90.
- Nishimori N, Izaki S, Kashimura T, Fujita H: A case of squamous cell carcinoma arising from plasma cell cheilitis. International Journal of Dermatology 2021 Aug; 61(6): e232-e233.
- Takahagi S, Kamegashira A, Inomata N, Fukunaga A, Nakahara T, Hayama K, Hide M: Impact of physicians' clinical experience and workplace on patients' care of urticaria in Japan: A sub-analysis of a nation-wide cross-sectional web questionnaire survey. Journal of Cutaneous Immunology and Allergy. 2021 Nov. [Online ahead of print]
- Fujita H, Gooderham M, Romiti R: Diagnosis of Generalized Pustular Psoriasis. American Journal of Clinical Dermatology 2022; 23(Suppl 1): 31-38.
2020年
原著・症例報告・総説 (英文のみ)
- Endo T, Toyoshima S, Hayama K, Tagui M, Niwa Y, Ito M, Terui T, Okayama Y: Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria. Asia Pacific Allergy 2020 Apr; 10(2): e12.
- Murakami M, Terui T: Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism. Journal of Dermatological Science 2020 Apr; 98(1): 13-19.
- Yamamoto T, Hiraiwa T, Tobita R, Hirano H, Masuda-Kuroki K, Ishii M, Murakami M, Terui T, Okubo Y: Characteristics of Japanese patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis: a multicenter study. International Journal of Dermatology 2020 Apr; 59(4): 441-444.
- Hayama K, Fujita H, Fujimaki M, Takahashi S, Yoshida Y, Nozaki T, Terui T: Rapid recurrence of dermatofibrosarcoma protuberans after initiation of adalimumab therapy in a patient with ankylosing spondylitis. Journal of Dermatology 2020 Jun; 47(6): e244-e246.
- Nishimura-Tagui M, Hayama K, Fujita H, Sato N, Nakamura M, Yagami A, Matsunaga K, Terui T: Case of anaphylaxis due to lotus root. Journal of Dermatology 2020 Jun; 47(6): e227-e228.
- Hayama K, Fujita H, Hashimoto T, Terui T, Japanese HS Research Group: Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries. Journal of Dermatology 2020 Jul; 47(7): 743-748.
- Kabashima K, Matsumura T, Komazaki H, Kawashima M, Nemolizumab-JP01 Study Group: Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus. The NEW ENGLAND JOURNAL of MEDICINE Med 2020 Jul; 383(2): 141-150. ※As a member of study group: Terui T
- Hasegawa M, Inoue Y, Kaneko S, Kanoh H, Shintani Y, Tsujita J, Fujita H, Motegi SI, Le Pavoux AJ, Asai J, Asano Y, Abe M, Amano M, Ikegami R, Ishii T, Isei T, Isogai Z, Ito T, Irisawa R, Iwata Y, Ohtsuka M, Omoto Y, Kato H, Kadono T, Kawakami T, Kawaguchi M, Kukino R, Kono T, Koga M, Kodera M, Sakai K, Sakurai E, Sarayama Y, Tanioka M, Tanizaki H, Doi N, Nakanishi T, Hashimoto A, Hayashi M, Hirosaki K, Fujimoto M, Fujiwara H, Maekawa T, Matsuo K, Madokoro N, Yatsushiro H, Yamasaki O, Yoshino Y, Tachibana T, Ihn H: Wound, Pressure Ulcer, and Burn Guidelines-1: Guidelines for wounds in general, second edition. Journal of Dermatology 2020 Aug; 47(8): 807-833.
- Fujiwara H, Isogai Z, Irisawa R, Otsuka M, Kadono T, Koga M, Hirosaki K, Asai J, Asano Y, Abe M, Amano M, Ikegami R, Ishii T, Isei T, Ito T, Inoue Y, Iwata Y, Omoto Y, Kato H, Kaneko S, Kanoh H, Kawakami T, Kawaguchi M, Kukino R, Kono T, Kodera M, Sakai K, Sakurai E, Sarayama Y, Shintani Y, Tanioka M, Tanizaki H, Tsujita J, Doi N, Nakanishi T, Hashimoto A, Hasegawa M, Hayashi M, Fujita H, Fujimoto M, Maekawa T, Matsuo K, Madokoro N, Motegi SI, Yatsushiro H, Yamasaki O, Yoshino Y, Pavoux AL, Tachibana T, Ihn H: Wound, pressure ulcer and burn guidelines-2: Guidelines for the diagnosis and treatment of pressure ulcers, second edition. Journal of Dermatology 2020 Sep; 47(9): 929-978.
- Fujimoto M, Asai J, Asano Y, Ishii T, Iwata Y, Kawakami T, Kodera M, Abe M, Amano M, Ikegami R, Isei T, Isogai Z, Ito T, Inoue Y, Irisawa R, Ohtsuka M, Omoto Y, Kato H, Kadono T, Kaneko S, Kanoh H, Kawaguchi M, Kukino R, Kono T, Koga M, Sakai K, Sakurai E, Sarayama Y, Shintani Y, Tanioka M, Tanizaki H, Tsujita J, Doi N, Nakanishi T, Hashimoto A, Hasegawa M, Hayashi M, Hirosaki K, Fujita H, Fujiwara H, Maekawa T, Matsuo K, Madokoro N, Motegi SI, Yatsushiro H, Yamasaki O, Yoshino Y, Le Pavoux AJ, Tachibana T, Ihn H: Wound, Pressure Ulcer, and Burn Guidelines-4: Guidelines for the management of connective tissue disease / vasculitis-associated skin ulcers. Journal of Dermatology 2020 Oct; 47(10): 1071-1109.
- Nishimori N, Hayama K, Kimura K, Fujita H, Fujiwara K, Terui T: A Novel NCSTN Gene Mutation in a Japanese Family with Hidradenitis Suppurativa. Acta Dermato- Venereologica 2020 Oct; 100(17): adv00283.
- Nakao M, Sugaya M, Fujita H, Miyagaki T, Morimura S, Shibata S, Asano Y, Sato S: TLR2 deficiency exacerbates imiquimod-induced psoriasis-like skin inflammation through decrease in regulatory T cells and impaired IL-10 production. International Journal of Molecular Sciences 21(22): 8560.
- Yoshino Y, Amano M, Omoto Y, Kawaguchi M, Sakai K, Doi N, Hashimoto A, Hayashi M, Madokoro N, Asai J, Asano Y, Abe M, Ikegami R, Ishii T, Isei T, Isogai Z, Ito T, Inoue Y, Irisawa R, Iwata Y, Ohtsuka M, Kato H, Kadono T, Kaneko S, Kanoh H, Kawakami T, Kukino R, Kono T, Koga M, Kodera M, Sakurai E, Sarayama Y, Shintani Y, Tanioka M, Tanizaki H, Tsujita J, Nakanishi T, Hasegawa M, Hirosaki K, Fujita H, Fujimoto M, Fujiwara H, Maekawa T, Matsuo K, Motegi SI, Yatsushiro H, Yamasaki O, Le Pavoux AJ, Tachibana T, Ihn H: Wound, Pressure Ulcer, and Burn Guidelines-6: Guidelines for the Management of Burns, second edition. Journal of Dermatology 2020 Nov; 47(11): 1207-1235.
- Morita A, Takahashi H, Ozawa K, Imafuku S, Takekuni N, Takahashi K, Matsuyama T, Okubo Y, Zhao Y, Kitamura S, Takei K, Yokoyama M, Hayashi N, Terui T: Long-term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open-label phase 3 results. Journal of Dermatology 2021 Jan; 48(1): 3-13.
- Fujita H, Ohtsuki M, Morita A, Nagao R, Seko N, Matsumoto K, Tani Y, Terui T: Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real-world evidence in Japan. Journal of Dermatology 2021 Feb; 48(2): 175-183.
- Hayama K, Fujita H, Asai-Sato M, Kawana K, Terui T: Successful treatment of intractable chronic spontaneous urticaria with omalizumab in a patient with ovarian cancer. European Journal of Dermatology 2021 Feb; 31(1): 100-101.
- Hayama K, Fujita H, Iwatsuki K, Terui T: Improved quality of life of patients with generalized pustular psoriasis in Japan: A cross-sectional survey. Journal of Dermatology 2021 Feb; 48(2): 203-206.
- Ikumi N, Fujita H, Terui T: Guselkumab improves joint pain in patients with pustulotic arthro-osteitis: A retrospective pilot study. Journal of Dermatology 2021 Feb; 48(2): 199-202.
- Ohtsuka M, Hamada T, Miyagaki T, Shimauchi T, Yonekura K, Kiyohara E, Fujita H, Izutsu K, Okuma K, Kawai K, Koga H, Sugaya M: Outlines of the Japanese Guidelines for the Management of Primary Cutaneous Lymphomas 2020. Journal of Dermatology 2021 Feb; 48(2): e49-e71.
- Izaki S, Hayama K, Fujita H: A case of contact dermatitis due to dental surface anaesthetic. Contact Dermatitis 2021; 84(3): 210-212.
- Toyoshima S, Sakamoto-Sasaki T, Kurosawa Y, Hayama K, Matsuda A, Watanabe Y, Terui T, Gon Y, Matsumoto K, Okayama Y: miR103a-3p in extracellular vesicles from FcεRI-aggregated human mast cells enhances IL-5 production by group 2 innate lymphoid cells. Journal of Allergy and Clinical Immunology 2021; 147(5):1878-1891.
- Farkas F, Ikumi N, Elmamoun M, Szentpetery A, FitzGerald O: Comparison of Composite Measure Remission Targets in Psoriatic Arthritis. The Journal of Rheumatology 2021 Mar; 23(Suppl 1): 31-38.
- Zouboulis CC, Benhadou F, Byrd AS, Chandran NS, Giamarellos-Bourboulis EJ, Fabbrocini G, Frew JW, Fujita H, González-López MA, Guillem P, Gulliver WPF, Hamzavi I, Hayran Y, Hórvath B, Hüe S, Hunger RE, Ingram JR, Jemec JBE, Ju Q, Kimball AB, Kirby JS, Konstantinou MP, Lowes MA, MacLeod AS, Martorell A, Marzano AV, Matusiak L, Nassif A, Nikiphorou E, Nikolakis G, Nogueira da Costa A, Okun MM, Orenstein LAV, Pascual JC, Paus R, Perin B, Prens EP, Röhn TA, Szegedi A, Szepietowski JC, Tzellos T, Wang B, van der Zee HH: What causes hidradenitis suppurativa? – 15 years after. Experimental Dermatology 2020 Dec; 29(12): 1154-1170.
